NCI | Technology Transfer

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

Read more about Combination Therapy of Immunotoxin and Checkpoint Inhibitor

European Patent
21193555.6
Filed on 2021-08-27

T CELL RECEPTORS RECOGNIZING MUTATED P53

Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53

Brazil
BR122021018454-2
Filed on 2021-09-16

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Brazil
BR122021018418-6
Filed on 2021-09-16

Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon

Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon

China
202110829496.3
Filed on 2021-07-22

TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS

Read more about TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS

Patent Cooperation Treaty
PCT/US2021/034339
Filed on 2021-05-26

HYBRID NUCLEIC ACID SWITCHES

Read more about HYBRID NUCLEIC ACID SWITCHES

US Application 17/602,204
Filed on 2021-10-07

Anti-Human Papillomavirus 16 E6 T Cell Receptors

Read more about Anti-Human Papillomavirus 16 E6 T Cell Receptors

Japan
2021-166407
Filed on 2021-10-08

Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Read more about Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Patent Cooperation Treaty
PCT/US2021/057229
Filed on 2021-10-29

Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

Read more about Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

US Application 17/745,067
Filed on 2022-05-16

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Sweden
18720845.9
Filed on 2018-04-05

Subscribe to NCI